tiprankstipranks
Trending News
More News >
Plandai Biotechnology Inc (PLPL)
OTHER OTC:PLPL
US Market

Plandai Biotechnology (PLPL) Income Statement

Compare
33 Followers

Plandai Biotechnology Income Statement

Last quarter (Q4 2023), Plandai Biotechnology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Plandai Biotechnology's net income was $-3.60M. See Plandai Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 3.81M$ 705.50K$ 24.27K$ 105.00K$ 0.00
Depreciation and Amortization
$ 19.84M$ 228.49K$ 236.56K$ 206.30K$ 171.86K
EBITDA
$ 35.88M$ -19.55M$ 7.18M$ -105.00K$ 171.86K
Operating Income
$ -3.81M$ -710.15K$ -24.27K$ -105.00K$ 0.00
Other Income/Expenses
$ 19.84M$ -19.09M$ 6.85M$ -292.00K$ -83.48K
Pretax Income
$ 16.03M$ -19.80M$ 6.82M$ -397.00K$ -83.48K
Net Income
$ 16.03M$ -19.80M$ 6.82M$ -397.00K$ -83.48K
Per Share Metrics
Basic EPS
$ <0.01$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ <0.01$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
44.89B 7.55B 6.37B 2.62B 825.41M
Weighted Average Shares Outstanding (Diluted)
44.89B 7.57B 7.06B 2.62B 825.41M
Currency in USD

Plandai Biotechnology Earnings and Revenue History